Evolving Considerations for Prevention and Management of COVID 19—Let’s Not Forget the Immunocompromised Patient!
|Content Release Date: 2/8/2023
Expiration Date: 7/1/2024
Activity Type: Application-based
CE Credits: 1.5 contact hours (0.15 CEUs)
Activity Fee: Free
This presentation will highlight expert guidance for optimizing treatment and prevention of COVID-19 in the immunocompromised as well as strategies for reaching the target population and provides 1.50 hours of continuing pharmacy education credit.
Evolving Considerations for Prevention and Management of COVID 19—Let’s Not Forget the Immunocompromised Patient!*
COVID-19 continues to pose a significant health risk, especially to those who cannot receive or do not respond to vaccination. As new variants emerge and data become available, it is important for pharmacists to stay abreast of these changes. This presentation will highlight expert guidance for optimizing treatment and prevention of COVID-19 in the immunocompromised as well as strategies for reaching the target population.
Engaging the Experts Podcasts
Tune in for additional insights and perspectives
from our faculty experts.
|CE Credits: 1.5 hours||CE Credits: none||CE Credits: none|
*Please note, this activity was presented live on December 6, 2022 as part of the ASHP 2022 Midyear Clinical Meeting & Exhibition. You can only claim credit once for this activity; live or home study
This activity was planned to meet the educational needs of pharmacists who want to optimize treatment and prevention of COVID-19 in the immunocompromised population.
After participating in this CPE activity, learners should be able to:
ACPE Number: 0204-0000-22-423-H01-P
- Describe the pharmacist’s role in prevention and treatment strategies for immunocompromised patients at risk for COVID-19 infection
- Discuss the role of pre-exposure prophylaxis in an immunocompromised patient
- Create a treatment plan for an immunocompromised patient with COVID-19 infection
- Summarize prevention and management strategies for COVID-19 in immunocompromised pediatric patients
Katherine Yang, PharmD, MPH, FCSHP
Health Sciences Clinical Professor of Pharmacy
University of California, San Francisco (UCSF) School of Pharmacy
Infectious Diseases Clinical Pharmacist
UCSF Medical Center
San Francisco, California
Monica V. Mahoney PharmD, BCPS, BCIDP, FCCP
Clinical Pharmacy Specialist, Infectious Diseases
Outpatient ID/OPAT Clinics
Beth Israel Deaconess Medical Center
Senior Director, Pharmacy Practice and Quality
Sarah Parsons, PharmD, BCPPS
Clinical Pharmacy Specialist Pediatric Infectious Diseases
Antimicrobial Stewardship, Cystic Fibrosis
The Children's Hospital of the King's Daughters
Relevant Financial Relationship Disclosures
Methods and CE Requirements
Activities can be completed in any order. Each activity consists of audio and video and an evaluation. Learners must review all content and complete an evaluation to receive continuing education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Important Note – ACPE 60 Day Deadline
Provided by ASHP
Supported by an educational grant from AstraZeneca Inc.